ARA-C AND AMSA IN THE THERAPY OF RELAPSED AND REFRACTORY ACUTE MYELOID-LEUKEMIA

被引：0
|
作者：
JAGER, U [1 ]
机构：
[1] VIENNA UNIV,MED KLIN 1,A-1010 VIENNA,AUSTRIA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 1986年 / 98卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：589 / 589
页数：1
相关论文
共 50 条
  • [41] Phase I study of UCN-01 and ara-C for patients with refractory or relapsed acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Cortes, J
    Plunkett, WK
    Estey, EH
    Keating, MJ
    Madden, T
    Sampath, D
    Faderl, S
    Beran, M
    Dancey, J
    Kantarjian, HM
    BLOOD, 2001, 98 (11) : 211B - 211B
  • [42] Salvage therapy for relapsed or refractory acute myeloid leukemia
    Mangan, James K.
    Luger, Selina M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (02) : 73 - 82
  • [43] LOW-DOSE CYTARABINE (ARA-C) IN THE TREATMENT OF MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    MUFTI, GJ
    OSCIER, DG
    HAMBLIN, TJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 61 (03) : 571 - 571
  • [44] Amonafide and ara-C treatment for secondary acute myeloid leukemia (sAML)
    Erba, H. P.
    Rizzieri, D. A.
    O'Donnell, M. R.
    Lundberg, A. S.
    Ajami, A. M.
    Rampersad, A. D.
    Capizzi, R. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] COMBINED ANTILEUKEMIC ACTIVITY OF PIXY-321 AND ARA-C AGAINST HUMAN ACUTE MYELOID-LEUKEMIA CELLS
    TANG, C
    HUANG, Y
    PONNATHPUR, VS
    RAY, S
    MAHONEY, ME
    BULLOCK, G
    IBRADO, AM
    BHALLA, K
    LEUKEMIA & LYMPHOMA, 1994, 15 (5-6) : 445 - 451
  • [46] Combination therapy with aclarubicine, etoposide and Ara-c (AVA) in the treatment of acute myeloid leukemia in the elderly
    Staib, P
    Lathan, B
    Steinmetz, HT
    Schwonzen, M
    KnoppelSchwark, S
    Wickramanayke, PD
    Tesch, H
    Diehl, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 852 - 852
  • [47] ENZYMATIC DETERMINANTS OF RESPONSE TO CYTOSINE-ARABINOSIDE (ARA-C) IN PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)
    RIVA, CM
    DESOUZA, G
    FERRIER, F
    MERLIN, M
    TUBIANA, N
    LEJEUNE, C
    GASTAUT, JA
    BARRA, Y
    CANO, JP
    CARCASSONNE, Y
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 502 - 502
  • [48] PRONOSTIC VALUE OF INVITRO UPTAKE AND RETENTION OF CYTOSINE-ARABINOSIDE (ARA-C) IN ACUTE MYELOID-LEUKEMIA (AML)
    MARIE, JP
    ZITTOU, R
    DELANIAN, S
    SUBERVILLE, AM
    THEVENIN, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 208 - 208
  • [49] A Phase Ib Dose-Finding Study of Oral Panobinostat In Combination with Cytarabine (ara-C) and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia (AML)
    Krauter, Jurgen
    Schlenk, Richard F.
    Schaich, Markus
    Bouscary, Didier
    Dombret, Herve
    Winiger, Ivo J.
    Squier, Margaret
    Bengoudifa, Bourras-Rezki
    Ottmann, Oliver G.
    BLOOD, 2010, 116 (21) : 1356 - 1356
  • [50] Fludarabine, Cytarabine (ARA-C) and Pegylated Erwinase (PEGCRISANTASPASE) in Patients with Relapsed or Refractory Leukemia
    Almanza, Emmanuel
    Bataller, Alex
    Garcia-Manero, Guillermo
    Maiti, Abhishek
    Montalban-Bravo, Guillermo
    Takahashi, Koichi
    Short, Nicholas J.
    Jabbour, Elias
    Ravandi, Farhad
    Valero, Yesid Alvarado
    Kadia, Tapan M.
    BLOOD, 2023, 142
12345